Ticker: XENE

Snapshot - Xenon Pharmaceuticals Inc. (NASDAQ: XENE) All figures below are taken from Xenon's Form 10‑Q for the quarter ended June 30, 2025 (amounts shown in the filing are expressed in thousands of U.S. dollars unless noted). What's happening inside the company * Xenon is heavily ramping late‑st...

Xenon Pharmaceuticals Inc. (NASDAQ: XENE) has recently published its quarterly report for the period ending March 31, 2025. The company continues to invest heavily in its drug development pipeline, focusing on azetukalner, a treatment for epilepsy and other neurological disorders, while facing on...